Genescopy encourages colonoscopy with noninvasive CRC screening test

Geneoscopy Inc. announced favorable results from its CRC-PREVENT trial, which assessed noninvasive, stool-based, at-home screening for colorectal cancer and advanced adenomas.Geneoscopy’s stool test uses patented RNA biomarker technology to screen for CRC and advanced adenomas that might indicate a higher risk of developing cancer.“Since the onset of the pandemic, patients’ demand for convenient at-home testing has increased and desire to complete invasive procedures in the office has decreased,” Erica Barnell, PhD, chief scientific officer and co-founder ofRead More

Generated by Feedzy